Related Experiment Video
Updated: Jul 30, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review
Yulin Qin1, Jinxin Wang2, Quanzhen Lv2
1Department of Pharmacy, Minhang Hospital, Fudan University, Shanghai, China.
Abstract:
Fungal infections, which commonly occur in immunocompromised patients, can cause high morbidity and mortality. Antifungal agents act by disrupting the cell membrane, inhibiting nucleic acid synthesis and function, or inhibiting β-1,3-glucan synthase. Because the incidences of life-threatening fungal infections and antifungal drug resistance are continuously increasing, there is an urgent need for the development of new antifungal agents with novel mechanisms of action. Recent studies have focused on mitochondrial components as potential therapeutic drug targets, owing to their important roles in fungal viability and pathogenesis. In this review, we discuss novel antifungal drugs targeting mitochondrial components and highlight the unique fungal proteins involved in the electron transport chain, which is useful for investigating selective antifungal targets. Finally, we comprehensively summarize the efficacy and safety of lead compounds in clinical and preclinical development. Although fungus-specific proteins in the mitochondrion are involved in various processes, the majority of the antifungal agents target dysfunction of mitochondria, including mitochondrial respiration disturbance, increased intracellular ATP, reactive oxygen species generation, and others. Moreover, only a few drugs are under clinical trials, necessitating further exploration of possible targets and development of effective antifungal agents. The unique chemical structures and targets of these compounds will provide valuable hints for further exploiting new antifungals.
Insights
New antifungal drugs targeting fungal mitochondria are crucial due to rising drug resistance. This review explores novel agents and targets, focusing on the electron transport chain for effective treatments.
Area of Science:
- Mycology
- Pharmacology
- Biochemistry
Background:
- Fungal infections pose significant threats, especially to immunocompromised individuals, leading to high morbidity and mortality.
- Increasing antifungal drug resistance necessitates novel therapeutic strategies beyond traditional targets like cell membranes or cell walls.
- Mitochondria play critical roles in fungal viability and pathogenesis, presenting them as promising targets for new antifungal drug development.
Purpose of the Study:
- To review novel antifungal drugs that specifically target mitochondrial components.
- To highlight unique fungal proteins within the electron transport chain as potential selective antifungal targets.
- To summarize the efficacy and safety of lead compounds currently in clinical and preclinical development.
Main Methods:
- Literature review of recent studies on antifungal agents targeting mitochondrial components.
- Analysis of unique fungal proteins involved in mitochondrial function, particularly the electron transport chain.
- Comprehensive summary of preclinical and clinical data for lead antifungal compounds.
Main Results:
- The majority of novel antifungal agents targeting mitochondria disrupt mitochondrial respiration, leading to increased ATP, reactive oxygen species generation, and other dysfunctions.
- Unique fungal proteins in the electron transport chain are identified as selective targets for antifungal drug development.
- Several lead compounds targeting mitochondrial dysfunction are in various stages of clinical and preclinical development.
Conclusions:
- Targeting fungal mitochondria, especially the electron transport chain, offers a promising avenue for developing new antifungal agents to combat drug resistance.
- Further exploration of mitochondrial targets and development of effective antifungal agents are urgently needed, as few drugs are currently in clinical trials.
- The unique chemical structures and targets of these novel compounds provide valuable insights for future antifungal drug discovery efforts.
More Related Videos
08:54Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Fungal Phylum Microsporidia
The Inner Mitochondrial Membrane
Mitochondrial Membranes